Rein Therapeutics Inc (RNTX) Balance Sheet
RNTX balance sheet, 2025
December 31, 2025 · U.S. dollars$24.2M assets = $7.2M liabilities + $16.9M equity
Both columns are drawn to the same scale: what RNTX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
RNTX financial health
Descriptive bands, not a rating. Fiscal 2025.
RNTX balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $22.0M2016 | $24.2M2025 | +1.0%/yr | |
| Total liabilities | $133.8M2016 | $7.2M2025 | −27.7%/yr | |
| Shareholders’ equity | −$111.8M2016 | $16.9M2025 | — | |
| Cash & short-term investments | $20.7M2016 | $3.2M2025 | −18.7%/yr | |
| Total debt | $5.3M2018 | $48,0002023 | −61.0%/yr | |
| Net cash (debt) | $15.4M2018 | $17.3M2023 | +$1.9M | |
| Working capital | $17.0M2016 | −$1.9M2025 | −$18.9M | |
| Book value per share | $0.702020 | $0.662025 | −1.0%/yr | |
| Current ratio | 5.182016 | 0.702025 | −4.48 | |
| Debt / equity | 0.272018 | 0.012023 | −0.27 | |
| Shares outstanding | 17.4M2020 | 25.4M2025 | +7.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
RNTX assets
RNTX liabilities and equity
RNTX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
RNTX balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $3.2M | $12.9M | $17.3M | $21.2M | $45.9M | $13.8M | $18.3M | $20.7M | $50.8M | $20.7M |
| Cash & equivalents | $3.2M | $12.9M | $17.3M | $5.2M | $3.6M | $7.0M | $5.3M | $10.6M | $11.9M | $20.7M |
| Short-term investments | — | — | $0 | $16.0M | $42.3M | $6.8M | $13.0M | $10.1M | $38.9M | — |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $1.1M | $792,000 | $953,000 | $631,000 | $2.2M | $2.5M | $1.3M | $1.1M | $1.1M | $358,000 |
| Total current assets | $4.3M | $13.7M | $18.3M | $21.9M | $48.2M | $16.3M | $19.6M | $21.8M | $51.8M | $21.1M |
| Property, plant & equipment (net) | $0 | $1,000 | $19,000 | $110,000 | $280,000 | $15,000 | $6.4M | $7.3M | $154,000 | $107,000 |
| Goodwill & intangible assets | $19.8M | $54.9M | $85.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $2,000 | $722,000 | $2.2M | $24,000 | $24,000 | $0 | $568,000 | $1.2M | $694,000 | $841,000 |
| Total assets | $24.2M | $69.2M | $106.0M | $22.0M | $48.5M | $16.3M | $26.5M | $30.3M | $52.7M | $22.0M |
| Liabilities | ||||||||||
| Accounts payable | $4.0M | $911,000 | $1.2M | $1.7M | $1.2M | $1.6M | $1.5M | $1.7M | $1.6M | $2.0M |
| Short-term debt | — | — | $48,000 | $33,000 | $93,000 | $168,000 | $446,000 | — | — | — |
| Total current liabilities | $6.2M | $5.7M | $4.4M | $3.4M | $4.5M | $4.0M | $5.8M | $5.4M | $4.9M | $4.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $219,000 | $0 | $0 | $0 | $0 |
| Lease obligations | — | $0 | $48,000 | $33,000 | $162,000 | $0 | — | — | — | — |
| Other long-term liabilities | $1.1M | $9.1M | $94.7M | $0 | $69,000 | $0 | $4.6M | $5.3M | $0 | $129.8M |
| Total liabilities | $7.2M | $14.8M | $99.1M | $3.4M | $4.6M | $4.2M | $10.4M | $10.7M | $4.9M | $133.8M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $113,000 | $108,000 | $91,000 | $91,000 | $91,000 | $44,000 | $28,000 | $15,000 | $15,000 | — |
| Retained earnings (deficit) | −$401.3M | −$351.4M | −$288.5M | −$272.8M | −$245.5M | −$219.3M | −$198.1M | −$168.5M | −$136.9M | −$114.3M |
| Accumulated other comprehensive income | −$62,000 | −$18,000 | −$63,000 | −$48,000 | −$13,000 | −$2,000 | $7,000 | −$5,000 | −$33,000 | — |
| Total shareholders' equity | $16.9M | $54.4M | $6.9M | $18.6M | $43.9M | $12.2M | $16.0M | $19.6M | $47.8M | −$111.8M |
| Key figures | ||||||||||
| Total debt | — | — | $48,000 | $33,000 | $162,000 | $387,000 | $5.0M | $5.3M | — | — |
| Net cash (debt) | — | — | $17.3M | $21.2M | $45.8M | $13.4M | $13.2M | $15.4M | — | — |
| Working capital | −$1.9M | $7.9M | $13.9M | $18.5M | $43.7M | $12.4M | $13.7M | $16.4M | $46.9M | $17.0M |
| Tangible book value | −$2.9M | −$468,000 | −$78.6M | $18.6M | $43.9M | $12.2M | $16.0M | $19.6M | $47.8M | −$111.8M |
| Book value per share | $0.66 | $3.03 | — | — | — | $0.70 | — | — | — | — |
| Shares outstanding | 25.4M | 17.9M | — | — | — | 17.4M | — | — | — | — |
| Current ratio | 0.70 | 2.38 | 4.17 | 6.46 | 10.69 | 4.12 | 3.35 | 4.05 | 10.60 | 5.18 |
| Quick ratio | 0.52 | 2.24 | 3.95 | 6.28 | 10.19 | 3.49 | 3.13 | 3.85 | 10.38 | 5.09 |
| Debt / equity | — | — | 0.01 | 0.00 | 0.00 | 0.03 | 0.31 | 0.27 | — | — |
| Equity / assets | 70.0% | 78.6% | 6.5% | 84.6% | 90.6% | 74.4% | 60.6% | 64.7% | 90.7% | −507.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $40.6M | $4.4M | $3.2M | $4.0M | $5.7M | $7.4M | $12.9M | $17.7M | $21.9M | $12.0M | $17.3M | $12.1M |
| Cash & equivalents | $8.5M | $4.4M | $3.2M | $4.0M | $5.7M | $7.4M | $12.9M | $17.7M | $21.9M | $12.0M | $17.3M | $12.1M |
| Short-term investments | $32.1M | — | — | — | — | — | — | — | — | — | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $806,000 | $1.0M | $1.1M | $1.1M | $880,000 | $903,000 | $792,000 | $1.0M | $1.2M | $722,000 | $953,000 | $724,000 |
| Total current assets | $41.5M | $5.5M | $4.3M | $5.2M | $6.6M | $8.3M | $13.7M | $18.7M | $23.2M | $12.8M | $18.3M | $12.8M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $1,000 | $1,000 | $1,000 | $1,000 | $2,000 | $6,000 | $19,000 | $29,000 |
| Goodwill & intangible assets | $19.8M | $19.8M | $19.8M | $48.5M | $48.5M | $48.5M | $48.5M | $85.5M | $85.5M | $85.5M | $85.5M | $0 |
| Long-term investments | $3.0M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1.7M | $1.0M | $2,000 | $2,000 | $2.3M | $766,000 | $2,000 | $2,000 | $709,000 | $892,000 | $2.2M | $0 |
| Total assets | $66.0M | $26.3M | $24.2M | $53.7M | $57.5M | $57.6M | $62.2M | $104.2M | $109.4M | $99.2M | $106.0M | $12.8M |
| Liabilities | ||||||||||||
| Accounts payable | $4.5M | $6.3M | $4.0M | $4.1M | $6.0M | $1.1M | $911,000 | $1.1M | $782,000 | $2.2M | $1.2M | $484,000 |
| Short-term debt | — | $4.9M | — | — | — | — | — | — | — | — | $48,000 | — |
| Total current liabilities | $9.7M | $13.6M | $6.2M | $5.7M | $7.7M | $6.0M | $5.7M | $5.7M | $4.9M | $4.5M | $4.4M | $1.6M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $48,000 | $0 |
| Other long-term liabilities | $1.1M | $1.1M | $1.1M | $1.8M | $46.8M | $46.8M | $47.1M | $48.3M | $48.4M | $49.9M | $94.7M | $0 |
| Total liabilities | $55.8M | $14.7M | $7.2M | $7.5M | $54.5M | $52.8M | $7.8M | $54.0M | $53.4M | $54.4M | $99.1M | $1.6M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $172,000 | $114,000 | $113,000 | $111,000 | $131,000 | $108,000 | $108,000 | $108,000 | $107,000 | $103,000 | $91,000 | $91,000 |
| Retained earnings (deficit) | −$413.5M | −$407.1M | −$401.3M | −$369.3M | −$363.7M | −$356.9M | −$351.4M | −$310.4M | −$304.6M | −$295.6M | −$288.5M | −$281.2M |
| Accumulated other comprehensive income | −$69,000 | −$62,000 | −$62,000 | −$44,000 | −$44,000 | −$32,000 | −$18,000 | −$26,000 | −$22,000 | −$63,000 | −$63,000 | — |
| Total shareholders' equity | $10.2M | $11.6M | $16.9M | $46.2M | $3.0M | $4.9M | $54.4M | $50.2M | $56.0M | $44.8M | $6.9M | $11.2M |
| Key figures | ||||||||||||
| Total debt | — | $4.9M | — | — | — | — | — | — | — | — | $48,000 | — |
| Net cash (debt) | — | −$478,000 | — | — | — | — | — | — | — | — | $17.3M | — |
| Working capital | $31.7M | −$8.2M | −$1.9M | −$570,000 | −$1.1M | $2.4M | $7.9M | $13.0M | $18.2M | $8.2M | $13.9M | $11.2M |
| Tangible book value | −$9.6M | −$8.2M | −$2.9M | −$2.3M | −$45.5M | −$43.7M | $5.9M | −$35.3M | −$29.5M | −$40.8M | −$78.6M | $11.2M |
| Book value per share | $0.34 | $0.38 | $0.66 | $1.75 | $0.12 | $0.21 | — | $2.32 | $2.81 | — | — | — |
| Shares outstanding | 30.4M | 30.4M | 25.4M | 26.4M | 24.2M | 22.9M | — | 21.7M | 19.9M | — | — | — |
| Current ratio | 4.27 | 0.40 | 0.70 | 0.90 | 0.86 | 1.39 | 2.38 | 3.30 | 4.69 | 2.82 | 4.17 | 7.88 |
| Quick ratio | 4.19 | 0.33 | 0.52 | 0.70 | 0.74 | 1.24 | 2.24 | 3.12 | 4.44 | 2.66 | 3.95 | 7.43 |
| Debt / equity | — | 0.42 | — | — | — | — | — | — | — | — | 0.01 | — |
| Equity / assets | 15.5% | 44.1% | 70.0% | 86.0% | 5.2% | 8.5% | 87.5% | 48.2% | 51.2% | 45.1% | 6.5% | 87.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 26, 2026); data from EODHD.
RNTX financial position
At the end of fiscal 2025 (December 31, 2025), Rein Therapeutics had total assets of $24.2 million (down 65.1% from a year earlier), total liabilities of $7.2 million and shareholders' equity of $16.9 million. Its current ratio was 0.70. In the latest quarter (ended June 30, 2026) total assets were $66.0 million and equity $10.2 million.
Related: RNTX income statement, RNTX cash flow statement, RNTX key metrics. See the RNTX stock overview for the latest quote and news.
RNTX balance sheet FAQ
What are Rein Therapeutics's total assets?
Rein Therapeutics reported total assets of $24.2 million at the end of fiscal 2025 (December 31, 2025), compared with $69.2 million a year earlier.
How much cash does Rein Therapeutics have?
Rein Therapeutics held $3.2 million in cash and short-term investments at the end of fiscal 2025.
What is Rein Therapeutics's book value?
Rein Therapeutics's shareholders' equity (book value) was $16.9 million at the end of fiscal 2025, or $0.66 per share.
What is Rein Therapeutics's current ratio?
Rein Therapeutics had current assets of $4.3 million and current liabilities of $6.2 million, a current ratio of 0.70 (current liabilities exceed current assets).
How much goodwill does Rein Therapeutics have?
Rein Therapeutics carried $19.8 million of goodwill and intangible assets, 82.1% of total assets, at the end of fiscal 2025.